Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0699790 (
colon cancer
)
28,837
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The p53 tumor suppressor protein induces cell cycle arrest or apoptosis in response to cellular stresses. We have identified
PRG3
(p53-responsive gene 3), which is induced specifically under p53-dependent apoptotic conditions in human
colon cancer
cells, and encodes a novel polypeptide of 373 amino acids with a predicted molecular mass of 40.5 kDa.
PRG3
has significant homology to bacterial oxidoreductases and the apoptosis-inducing factor, AIF, and the gene was assigned to chromosome 10q21.3-q22.1. Expression of
PRG3
was induced by the activation of endogenous p53 and it contains a p53-responsive element. Unlike AIF,
PRG3
localizes in the cytoplasm and its ectopic expression induces apoptosis. An amino-terminal deletion mutant of
PRG3
that lacks a putative oxidoreductase activity retains its apoptotic activity, suggesting that the oxidoreductase activity is dispensable for the apoptotic function of
PRG3
. The
PRG3
gene is thus a novel p53 target gene in a p53-dependent apoptosis pathway.
...
PMID:A novel p53-inducible apoptogenic gene, PRG3, encodes a homologue of the apoptosis-inducing factor (AIF). 1213 61